Clinical Site Partners, LLC dba Flourish Research

Miami, Florida 33186

0 studies enrolling now · 8 studies all time

What they study most

COVID-19, Gout, Gout Flare, Hyperuricemia, Influenza, Mixed Dyslipidemia, Obesity, Obstructive Sleep Apnea, Overweight, Seasonal Influenza, Severe Asthma, Tophi

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight — Completed
• Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications — Completed
• A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) — Running, not enrolling
• A Study in Patients With Mixed Dyslipidemia — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• Study of mRNA-1010 Seasonal Influenza Vaccine in Adults — Completed
• Study of Obeldesivir in Nonhospitalized Participants With COVID-19 — Completed